FOLD

AS OF

Nov 14, 01:06 PM (EDT)

Price

$9.51

Change

+$0.13 (+1.39%)

Capitalization

2.89B

97 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

FOLD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Amicus Therapeutics (FOLD) Earnings Date & Reports

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FOLD is expected to report earnings to rise 16.67% to 7 cents per share on February 19

Amicus Therapeutics FOLD Stock Earnings Reports

Q4'25

Est.

$0.07

Q3'25

Beat

by $0.03

Q2'25

Beat

by $0.12

Q1'25

Beat

by $0.05

Q4'24

Beat

by $0.08

The last earnings report on November 04 showed earnings per share of 5 cents, beating the estimate of 2 cents. With 355.55K shares outstanding, the current market capitalization sits at 2.89B.

View a ticker or compare two or three

Compare

Earnings Traders Earnings Traders

Annualized Return+26%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

FOLD

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FOLD showed earnings on November 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading for FOLD

A.I. Advisor

published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

47 Hulfish Street

Phone

+1 609 662-2000

Employees

517

Web

https://www.amicusrx.com